Flavanones for use in treating visceral hypersensitivity
AssigneeBioActor BV
InventorsAntonie Johannes Van der Saag, Bouke Salden, Sam Possemiers, Yala Stevens
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds of formula (I), such as hesperitin-7-rutinoside 2S, for use in the treatment of visceral hypersensitivity. Compounds and compositions of the invention are particularly useful in the treatment of visceral hypersensitivity in a subject having irritable bowel syndrome or age-associated low grade systemic inflammation of the gut, but lacking spasmodic intestinal contractions.
Claims5
A method for treating microbial dysbiosis and chronic low grade systemic inflammation in an elderly subject with microbial dysbiosis and chronic low grade systemic inflammation, the method comprising administering to the elderly subject a pharmaceutical composition comprising 50 mg to 1500 mg hesperidin per unit dosage.
Dependencies are inferred from the claim text.